Patents by Inventor Rosalind Segal

Rosalind Segal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss
    Publication number: 20230077821
    Abstract: Compositions and methods are provided for the treatment or prevention of chemotherapy-induced peripheral neuropathy and hearing loss in a subject in need thereof. The methods involve administering to the subject a bclw protein, a BH4 domain-containing fragment thereof, or a bclw mimetic. Also provided are exemplary bclw mimetics.
    Type: Application
    Filed: August 29, 2022
    Publication date: March 16, 2023
    Inventors: Rosalind Segal, Loren D. Walensky, Lisa V. Goodrich, Sarah Elizabeth Raissi, Maria F. Murphy, Gregory H. Bird
  • Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss
    Patent number: 11466064
    Abstract: Compositions and methods are provided for the treatment or prevention of chemotherapy-induced peripheral neuropathy and hearing loss in a subject in need thereof. The methods involve administering to the subject a bclw protein, a BH4 domain-containing fragment thereof, or a bclw mimetic. Also provided are exemplary bclw mimetics.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: October 11, 2022
    Assignees: Dana-Farber Cancer Institute, Inc., President and Fellows of Harvard College
    Inventors: Rosalind Segal, Loren D. Walensky, Lisa Vaughn Goodrich, Sarah Elizabeth Raissi, Maria F. Murphy, Gregory H. Bird
  • BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss
    Publication number: 20200352899
    Abstract: Compositions and methods are provided for the treatment or prevention of chemotherapy-induced peripheral neuropathy and hearing loss in a subject in need thereof. The methods involve administering to the subject a bclw protein, a BH4 domain-containing fragment thereof, or a bclw mimetic. Also provided are exemplary bclw mimetics.
    Type: Application
    Filed: August 25, 2017
    Publication date: November 12, 2020
    Inventors: Rosalind Segal, Loren D. Walensky, Lisa Vaughn Goodrich, Sara Elizabeth Raissi, Maria F. Murphy, Gregory H. Bird